• Home
  • About
    • Overview
    • Sharing Data
    • ORCID
  • Help
  • History (131)
    • Study design and outcomes measures: The influence of composite endpoints and other design variables on outcomes in a study of a novel device for stress urinary incontinence.
    • Percutaneous coronary intervention with second-generation paclitaxel-eluting stents versus everolimus-eluting stents in United States contemporary practice (REWARDS TLX Trial).
    • Expression and regulation of RAD51 mediate cellular responses to chemotherapeutics.
    • Seizure freedom as an outcome in epilepsy treatment clinical trials.
    • ACE inhibitor improves insulin resistance in diabetic mouse via bradykinin and NO.
    • See All 131 Pages
  • search
    • Find People
    • Find Everything
Login to edit your profile (add a photo, awards, links to other websites, etc.)
  • Edit My Profile
  • My Person List (0)

ACE inhibitor improves insulin resistance in diabetic mouse via bradykinin and NO.

ACE inhibitor improves insulin resistance in diabetic mouse via bradykinin and NO. Hypertension. 2002 Sep; 40(3):329-34.

View in: PubMed

subject areas
  • Angiotensin-Converting Enzyme Inhibitors
  • Animals
  • Biological Transport
  • Blood Glucose
  • Bradykinin
  • Cell Line
  • Deoxyglucose
  • Diabetes Mellitus, Type 2
  • Glucose Transporter Type 4
  • Insulin Receptor Substrate Proteins
  • Insulin Resistance
  • Kinetics
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Monosaccharide Transport Proteins
  • Muscle Proteins
  • Muscle, Skeletal
  • Nitric Oxide
  • Phosphoproteins
  • Phosphorylation
  • Protein Transport
  • Thiazepines

authors with profiles
  • Taixing Cui